BIOSYNGEN PTE. LTD.
Last Updated: 13 Apr 2026
Biosyngen is a cell therapy company focused on addressing unmet medical needs through innovative technology. Our pipeline includes Phase I/II clinical trials for nasopharyngeal cancer and lymphoproliferative disease, with plans for additional indications. We leverage a dual HQ structure in Singapore and Guangzhou, and have established GMP cell therapy manufacturing facilities in both locations. Our Translational Medicine Centre is a public-private-partnership hub connecting stakeholders in R&D, clinical development, hospitals, pharma, enterprises, and venture capital. Committed to improving patient outcomes, we seek breakthroughs in collaborations and cutting-edge technologies to bring new treatments to market.
Country of registration | Singapore |
Registration number | 201618108R |
Local SIC | |
Incorporation date | 1 Jul 2016 |
Company age | 9 years 11 months |
Official entity type | Private Limited Company |
No. of officers | 68 |
Contact
Address:
5 TAI SENG AVENUE, #08-51/54, TAI SENG EXCHANGE, Singapore 536671
Access Key Decision Makers
This is the legal entity page of BIOSYNGEN PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
Associated business (1)
- BIOSYNGENView MoreSingaporeBiosyngen is a cell therapy company focused on addressing unmet medical needs through innovative technology. Our pipeline includes Phase I/II clinical trials for nasopharyngeal cancer and lymphoproliferative disease, with plans for additional indications. We leverage a dual HQ structure in Singapore and Guangzhou, and have established GMP cell therapy manufacturing facilities in both locations. Our Translational Medicine Centre is a public-private-partnership hub connecting stakeholders in R&D, clinical development, hospitals, pharma, enterprises, and venture capital. Committed to improving patient outcomes, we seek breakthroughs in collaborations and cutting-edge technologies to bring new treatments to market.
This is the legal entity page of BIOSYNGEN PTE. LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.
Financials
Fiscal/Budgeting Period | October - December |
Auditor | CS PRACTICE PAC |
Revenue | 1m - 5m |
Financial period end date | 31 Dec 2021 |
Share Capital - Ordinary shares | SGD 32,318,958 |
Last updated: 13 Apr 2026
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Discover More Companies
Lookalike companies
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.
Frequently Asked Questions (FAQ)
- What is the address of BIOSYNGEN PTE. LTD.?
- Where is BIOSYNGEN PTE. LTD.'s headquarter?
- What is BIOSYNGEN PTE. LTD.'s contact number?
- What BIOSYNGEN PTE. LTD.'s spending power?
- Does BIOSYNGEN PTE. LTD. have a presence in the domain it operates in?